What the analyst said

Cantor Fitzgerald analyst C.J.

Muse raised the price target on Lam Research (NASDAQ: LRCX) to $500.00 (from $425.00) while maintaining an Overweight rating.

“While we favor ASML on pure earnings upside, we continue to see buying opportunities depending on investor preference for the rest of the group.

AMAT remains the most optically inexpensive (36x CY27 vs. LRCX 44x, KLAC 47x, and ASML 39x), LRCX looks to be gaining the most share, while KLAC is the most defensive name in the group.

In general, we continue to be “All-in” on Semi Cap as Investors begin to discount growing WFE forecasts extending out through CY30, resulting in growing earnings power for essentially every name in the ecosystem.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

LRCX trades at $185. The 9 analysts who set a target in the last 3 months range from $290 to $400, with a median of $350. This $500 target is 43% above the median, the highest on the Street.

Since the note LRCX has moved −51% (from $379). 12-month window: day 129 of 365, closes on June 29, 2027.

Track record

This callOpen: LRCX has not reached $500 yet. This 12-month target is scored on June 29, 2027.

Firm track recordCantor: 80% of its 55 targets at least a year old were reached within 12 months (#10 of 26 firms). Accuracy ranking →

Cantor on Lam Research

Cantor price targets on Lam Research

5 calls from January 29, 2026 to June 29, 2026. The target went from $320 to $500 (+56%). The rating stayed Buy.

Cantor targetLRCX share price
  1. June 29, 2026 This noteTarget raised from $425 (+18%)Buy$500
  2. June 10, 2026Target raised from $320 (+33%)Buy$425
  3. April 30, 2026Kept the $320 targetBuy$320
  4. April 23, 2026Kept the $320 targetBuy$320
  5. January 29, 2026Earliest call shownBuy$320
Share

Other analysts on Lam Research

Lynx Equity Kept rating and price target Oct 28 $400maintained BernsteinBuy Cut price target −9%, kept rating Oct 22 $350from $385 UBSBuy Cut price target −6%, kept rating Oct 22 $400from $425 Morgan StanleyBuy Cut price target −12%, kept rating Oct 22 $339from $385 Bank of AmericaBuy Cut price target −10%, kept rating Oct 22 $345from $385
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.